While patient clinical data and metadata are now being collected ... process of creating drug candidates before any clinical testing can be considered. MTPC has found a powerful use for AI in ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...

The presentation titled " Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: ...

Regeneron bids for 23andMe for a discounted price of $256 million. The testing firm was once valued at $3.5 billion.

The team established reference ranges for each gene based on control data. To assess clinical performance, the team evaluated ...

Toop-line data from RISE UP, a clinical trial testing Agios' mitapivat for treating sickle cell disease, is expected by ...

This study demonstrates that integrating multi-analyte biomarker data from the Octave MSDA Test into clinical workflows enhances decision-making, particularly with repeated use, as confidence in ...

Additional clinical utility data on the Signatera Genome assay ... as an ultra-sensitive assay for the detection of ctDNA. The test’s bespoke assay is designed from a whole genome sequence ...